Clinical trials · Salt Lake City, UT
Relapsed Non-Hodgkin Lymphoma clinical trials in Salt Lake City
We’re tracking 8 recruiting relapsed non-hodgkin lymphoma studies with a site in or near Salt Lake City — including Phase 1, Phase 1/Phase 2 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Salt Lake City
- NCT07188558RecruitingPhase 3
Comparing ronde-cel to standard CAR T-cell therapy for large B-cell lymphoma
This trial tests a new treatment called ronde-cel against the usual CAR T-cell therapy for people with large B-cell lymphoma that has come back or not responded to initial treatment. The goal is to see if ronde-cel works better.
Salt Lake City, UtahAges 18 years+ - NCT05826535RecruitingPhase 1/Phase 2
Test of CAR T-cell therapy for aggressive B-cell lymphoma
This Phase 1/2 study tests a lab-made immune cell treatment (CAR T cells) made from your own blood cells to treat aggressive large B-cell lymphoma that has come back or didn’t respond. If you qualify, the goal is to see whether this treatment is safe and can shrink lymphoma.
Salt Lake City, UtahAges 18 years+ - NCT06173518RecruitingPhase 1
CAR T-cell therapy for children with B-cell leukemia or lymphoma
This trial tests a CAR T-cell therapy that targets CD19 on cancer cells. It is for children whose B-cell acute lymphoblastic leukemia or aggressive B-cell non-Hodgkin lymphoma has come back or not responded to other treatments.
Salt Lake City, UtahAges birth–18 years - NCT05476770RecruitingPhase 1
Tagraxofusp for children with CD123-positive leukemia
This study tests tagraxofusp, a medicine that targets a marker called CD123 on cancer cells, in children and young adults whose leukemia or lymphoma has come back or is resistant to treatment. It may help by shrinking the cancer and improving disease control after standard therapies have not worked.
Salt Lake City, UtahAges 1–21 - NCT05091424RecruitingPhase 1
Mosunetuzumab with or without venetoclax for CLL
This Phase 1 study tests whether mosunetuzumab alone or with venetoclax is safe and effective for people with chronic lymphocytic leukemia (CLL) that came back or did not respond to prior treatment. It may help by controlling the CLL immune system response while also studying dosing and side effects.
Salt Lake City, UtahAges 18 years+ - NCT04771572RecruitingPhase 1
Oral drug LP-118 for relapsed blood cancers
This Phase 1 study tests an oral (by mouth) drug called LP-118 in people whose blood cancers have returned or did not respond to prior treatment. The goal is to find a safe dose and see whether it can shrink or control the cancer.
Salt Lake City, UtahAges 13 years+ - NCT05332054Enrolling by invitation
Long-term follow-up after prior Caribou treatment
This study checks your health over time after you previously took a Caribou medicine (or got it through a special access program). It helps researchers learn what happens in the longer run after the treatment.
Salt Lake City, UtahAges 18 years+ - NCT05643742RecruitingPhase 1/Phase 2
Study of CTX112 for B-cell cancers that came back or did not respond
This Phase 1/2 study tests how safe and effective CTX112 is for adults whose B-cell cancer has returned or is not responding to treatment. It aims to see whether CTX112 can control the cancer while monitoring side effects closely.
Salt Lake City, UtahAges 18 years+
Hear when a new Relapsed Non-Hodgkin Lymphoma trial opens near Salt Lake City, UT
We’ll email you when one opens near Salt Lake City, UT — at most once a week, no account needed, unsubscribe anytime.
Relapsed Non-Hodgkin Lymphoma trials in other cities
Where these studies are running near Salt Lake City
Institutions with a site for the recruiting relapsed non-hodgkin lymphoma studies listed above.
- Huntsman Cancer Institute/University of Utah · 3 studies
- Intermountain Health · 2 studies
- Primary Children's Hospital · 2 studies
- University of Utah · 2 studies
What taking part in a relapsed non-hodgkin lymphoma study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Looking wider? See all recruiting relapsed non-hodgkin lymphoma studies in Utah.
Common questions
- Are there relapsed non-hodgkin lymphoma clinical trials near Salt Lake City?
- Yes. We're currently tracking 8 recruiting relapsed non-hodgkin lymphoma studies with a site near Salt Lake City, each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a relapsed non-hodgkin lymphoma study near Salt Lake City?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Salt Lake City to take part?
- Not necessarily. These studies have a site near Salt Lake City, but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a relapsed non-hodgkin lymphoma trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New relapsed non-hodgkin lymphoma studies open near Salt Lake City regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.